Epidemiology of sarcopenia in elderly Japanese

  • Yuki Atsumu
    Faculty of Education, Kochi University Section of the NILS-LSA, National Center for Geriatrics and Gerontology
  • Ando Fujiko
    Faculty of Health and Medical Sciences, Aichi Shukutoku University Section of the NILS-LSA, National Center for Geriatrics and Gerontology
  • Otsuka Rei
    Section of the NILS-LSA, National Center for Geriatrics and Gerontology
  • Matsui Yasumoto
    Department of Orthopedic Surgery, National Center for Geriatrics and Gerontology
  • Harada Atsushi
    Department of Orthopedic Surgery, National Center for Geriatrics and Gerontology
  • Shimokata Hiroshi
    Section of the NILS-LSA, National Center for Geriatrics and Gerontology Graduate School of Nutritional Sciences, Nagoya University of Arts and Sciences

この論文をさがす

抄録

Sarcopenia, a degenerative loss of skeletal muscle mass and strength, impacts daily life among the elderly. Because few cohort studies have examined muscle mass, muscular strength, physical performance, and probable confounding factors in detail, the prevalence of sarcopenia among the elderly in Japan is unclear. In this review, we examine the prevalence of sarcopenia based on the criteria of the Asian Working Group for Sarcopenia (AWGS) using a large-scale cohort of randomly selected community-dwelling elderly in Japan. Participants included 949 elderly (479 men and 470 women) aged 65-91 years who participated in the seventh wave examination of the National Institute for Longevity Sciences - Longitudinal Study of Aging between July 2010 and July 2012. The prevalence of low muscle mass was 43.2% in men and 20.2% in women. The prevalence of low muscle strength was 10.0% in men and 21.5% in women, and the prevalence of low physical performance was 5.4% in men and 9.2% in women. The prevalence of sarcopenia based on a diagnosis of low muscle mass, low muscle strength, and low physical performance was 9.6% in men and 7.7% in women. Elderly who were diagnosed with sarcopenia included 1,320,000 men and 1,400,000 women. These data could be of great help to clinicians and healthcare professionals and contribute to the development of prevention and treatment strategies for sarcopenia in Japan.

収録刊行物

被引用文献 (15)*注記

もっと見る

参考文献 (9)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ